[go: up one dir, main page]

DE602004006024D1 - Pharmazeutische zusammensetzung mit einem zink/hyaluronat-komplex zur behandlung von multipler sklerose - Google Patents

Pharmazeutische zusammensetzung mit einem zink/hyaluronat-komplex zur behandlung von multipler sklerose

Info

Publication number
DE602004006024D1
DE602004006024D1 DE602004006024T DE602004006024T DE602004006024D1 DE 602004006024 D1 DE602004006024 D1 DE 602004006024D1 DE 602004006024 T DE602004006024 T DE 602004006024T DE 602004006024 T DE602004006024 T DE 602004006024T DE 602004006024 D1 DE602004006024 D1 DE 602004006024D1
Authority
DE
Germany
Prior art keywords
zinc
treatment
multiple sclerosis
pharmaceutical composition
hyaluronate complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004006024T
Other languages
English (en)
Other versions
DE602004006024T2 (de
Inventor
Gyoergy Tibor Balogh
Janos Illes
Andras Boros
Gaborne Forrai
Akosne Szekely
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richter Gedeon Vegyeszeti Gyar Nyrt
Original Assignee
Richter Gedeon Vegyeszeti Gyar RT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszeti Gyar RT filed Critical Richter Gedeon Vegyeszeti Gyar RT
Publication of DE602004006024D1 publication Critical patent/DE602004006024D1/de
Application granted granted Critical
Publication of DE602004006024T2 publication Critical patent/DE602004006024T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE602004006024T 2003-11-20 2004-11-18 Pharmazeutische zusammensetzung mit einem zink/hyaluronat-komplex zur behandlung von multipler sklerose Expired - Lifetime DE602004006024T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU0303779A HUP0303779A2 (en) 2003-11-20 2003-11-20 Pharmaceutical compositions containing hyaluronan complex for the treatment of sclerosis multiplex
HU0303779 2003-11-20
PCT/HU2004/000107 WO2005049047A1 (en) 2003-11-20 2004-11-18 Pharmaceutical composition comprising a zinc-hyaluronate complex for the treatment of multiple sclerosis

Publications (2)

Publication Number Publication Date
DE602004006024D1 true DE602004006024D1 (de) 2007-05-31
DE602004006024T2 DE602004006024T2 (de) 2007-12-27

Family

ID=90001707

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004006024T Expired - Lifetime DE602004006024T2 (de) 2003-11-20 2004-11-18 Pharmazeutische zusammensetzung mit einem zink/hyaluronat-komplex zur behandlung von multipler sklerose

Country Status (19)

Country Link
US (1) US20070123488A1 (de)
EP (1) EP1699468B1 (de)
JP (1) JP4778908B2 (de)
CN (1) CN1882352B (de)
AT (1) ATE359800T1 (de)
CY (1) CY1106617T1 (de)
DE (1) DE602004006024T2 (de)
DK (1) DK1699468T3 (de)
EA (1) EA009209B1 (de)
ES (1) ES2286698T3 (de)
HR (1) HRP20070291T3 (de)
HU (1) HUP0303779A2 (de)
NO (1) NO336121B1 (de)
PL (1) PL1699468T3 (de)
PT (1) PT1699468E (de)
RS (2) RS50523B (de)
SI (1) SI1699468T1 (de)
UA (1) UA83516C2 (de)
WO (1) WO2005049047A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007153761A (ja) * 2005-12-01 2007-06-21 Toshitsu Kagaku Kenkyusho:Kk シナプス伝達促進剤及びシナプス保護剤
US20070099867A1 (en) * 2005-05-24 2007-05-03 Glycoscience Laboratories, Inc. Pharmaceutical agent containing hyaluronan as an active ingredient
RU2342148C2 (ru) * 2005-09-26 2008-12-27 Гликосайенс Лабораториз, Инк. Фармацевтическое средство, содержащее гиалуронан в качестве активного ингредиента
JP2009091248A (ja) * 2006-01-17 2009-04-30 Toshitsu Kagaku Kenkyusho:Kk 外傷性神経障害および／または運動機能障害の治療薬
EP1994934A4 (de) 2006-12-05 2010-03-10 Glycoscience Lab Inc Therapeutisches mittel gegen degenerative arthritis
JP2007277258A (ja) * 2007-06-20 2007-10-25 Toshitsu Kagaku Kenkyusho:Kk 炎症及び神経疾患の治療剤及び予防剤
EP2405749B1 (de) * 2009-08-20 2013-05-08 Yeda Research and Development Co., Ltd. Niedrigfrequente glatiramerazetattherapie
CN111647100B (zh) * 2020-07-14 2022-03-01 山东华熙海御生物医药有限公司 一种高分子量透明质酸锌的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU203372B (en) * 1989-02-24 1991-07-29 Richter Gedeon Vegyeszet Process for producing hyaluronic associates and pharmaceutical compositions and cosmetics comprising such active ingredient
JP3419785B2 (ja) * 1995-09-28 2003-06-23 サングスタット メディカル コーポレイション 免疫抑制剤としてのヒアルロン酸の使用
HU225991B1 (en) * 1997-04-29 2008-02-28 Richter Gedeon Nyrt Use of the zinc hyaluronate associate (complex) for the preparation of pharmaceutical compositions for oral use against peptic ulcer
DE19721099C2 (de) * 1997-05-20 1999-12-02 Fumapharm Ag Muri Verwendung von Fumarsäurederivaten
JP2003089647A (ja) * 1999-03-10 2003-03-28 Takada Seiyaku Kk 関節性疾患治療剤
JP2001163789A (ja) * 1999-12-13 2001-06-19 Maruho Co Ltd マトリックスメタロプロテアーゼ阻害用医薬組成物
BG104880A (en) * 2000-10-24 2002-04-30 Иван ХРИСТОВ Medicamentous preparation for multiple sclerosis treatment
CA2440744C (en) * 2001-03-15 2009-12-08 Seikagaku Corporation Il-12 expression controlling agent

Also Published As

Publication number Publication date
HK1098352A1 (en) 2007-07-20
SI1699468T1 (sl) 2007-08-31
NO20062857L (no) 2006-08-18
RS20060325A (sr) 2008-08-07
HRP20070291T3 (hr) 2007-10-31
HUP0303779A2 (en) 2006-02-28
EP1699468B1 (de) 2007-04-18
RS50523B (sr) 2010-05-07
UA83516C2 (uk) 2008-07-25
DK1699468T3 (da) 2007-09-03
WO2005049047A1 (en) 2005-06-02
DE602004006024T2 (de) 2007-12-27
PL1699468T3 (pl) 2007-09-28
EP1699468A1 (de) 2006-09-13
CN1882352A (zh) 2006-12-20
JP4778908B2 (ja) 2011-09-21
CN1882352B (zh) 2010-08-04
ES2286698T3 (es) 2007-12-01
ATE359800T1 (de) 2007-05-15
EA200600998A1 (ru) 2006-10-27
HUP0303779D0 (en) 2004-03-01
CY1106617T1 (el) 2012-01-25
US20070123488A1 (en) 2007-05-31
EA009209B1 (ru) 2007-12-28
PT1699468E (pt) 2007-06-05
NO336121B1 (no) 2015-05-18
JP2007512311A (ja) 2007-05-17

Similar Documents

Publication Publication Date Title
ATE465164T1 (de) Triazolopyrazinverbindungen zur behandlung von degenerations- und entzündungskrankheiten
EA200701296A1 (ru) 3,5-дизамещенные и 3,5,7-тризамещенные 3h-оксазоло- и 3h-тиазоло[4,5-d] пиримидин-2-оны и их пролекарства
WO2005004818A3 (en) Heterocyclic compounds and their use as anticancer agents
MY143795A (en) Tetrahydropyridoindole derivatives
AU2002218167A1 (en) N-phenyl-2-pyrimidine-amine derivatives
EP1933833B8 (de) Therapie zur behandlung der überaktiven blase
MY140840A (en) Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
WO2005056524A3 (en) Therapeutic agents useful for treating pain
WO2005037798A3 (en) Amide or thiomide derivatives and their use in the treatment of pain
ATE470443T1 (de) Indol-1-yl-essigsäurederivate
ATE441423T1 (de) Verwendung von mastix und dessen ätherischen ílen zur verhinderung oder bekämpfung von mikrobieller infektionen
TW200722081A (en) New therapeutic combinations for the treatment or prevention of depression
EP2215054B8 (de) Amidderivate als ionenkanalliganden sowie pharmazeutische zusammensetzungen und verwendungsverfahren dafür
EA200500871A1 (ru) Пептиды, ингибирующие ангиогенез, миграцию клеток, инвазию клеток и пролиферацию клеток, композиции и их применение
CY1106617T1 (el) Φαρμακευτικη συνθεση περιλαμβανουσα συμπλοκο ψευδαργυρου-υαλουρονικου για τη θεραπεια σκληρυνσης κατα πλακας
MXPA06014182A (es) Nucleosidos de 3-??-d-ribofuranosiltiazolo[4,5-d]piridimina y usos de los mismos.
TW200639159A (en) Treatment of pain
WO2005072246A3 (en) Facially amphiphilic polyaryl and polyarylalkynyl polymers and oligomers and uses thereof
MY146802A (en) Novel drugs for treating respiratory diseases
BRPI0507811A (pt) derivados de 7h-pirrolopirimidina
TNSN07283A1 (en) Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
PL1668021T3 (pl) Nowe związki tioksylozy, sposób ich przygotowania, zawierające je kompozycje farmaceutyczne i ich zastosowanie w lecznictwie
ATE346080T1 (de) Steroid-verbindungen mit anti-tumoraler wirkung
WO2004108094A3 (en) Sulfonamide-substituted chalcone derivatives and their use to treat diseases
WO2004018436A3 (fr) Composes derives d'arylcarbamates, preparation et utilisations

Legal Events

Date Code Title Description
8364 No opposition during term of opposition